Tirofiban plus aspirin and clopidogrel for mild stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You had a mild stroke that was not caused by a heart condition, and you can start treatment within 48 hours.
- Your stroke symptoms are mild (NIHSS score of 5 or less).
- You have not had a major bleed, recent surgery, or high bleeding risk (like blood thinners or low platelets).
- You do not have kidney failure, uncontrolled high blood pressure, or allergies to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a drug called tirofiban to aspirin can improve recovery outcomes in people who have had a moderate stroke. Tirofiban helps prevent new blood clots from forming, which may reduce the risk of further stroke and disability.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
This trial tests whether combining aspirin with a second antiplatelet drug (ticagrelor or clopidogrel) helps prevent another stroke after a mild stroke or TIA. It might lower your risk of having another event.
This trial tests whether taking aspirin along with either ticagrelor or cilostazol helps prevent another stroke in people who have had a mild stroke or transient ischemic attack (mini-stroke). You must start treatment within 24 hours of your first symptoms.
Hear when a new Mild Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.